This week, we discuss Vaccines for SARS-COV2 as well as monoclonal antibodies for the pandemic.
ACE2 and HYPERTENSION
There has been an unprecedented interest in this topic. Hence we have added more details and moved this section from the main page to a dedicated area with focus on hypertension and ACE2. Curated by Matt Sparks and Swapnil Hiremath, with additional expert input from the COVID-ACE2 workgroup